Search research articles
Contact Us
Filters
Showing results (251-260 of 382) with videos related to
Page
of 39
Sort By:
Clinical Transplantation
|
November 22, 2024
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
Ingelin Grov, Anne Relbo Authen, Satish Arora, et al.
Clinical Transplantation
|
June 23, 2017
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
Anne Relbo Authen, Ingelin Grov, Kristjan Karason, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 27, 2025
Chronic thromboembolic pulmonary hypertension
John-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Human Immunology
|
October 22, 2023
Kinetics of Torque Teno virus in heart transplant patients
Randi Berg, Tor S Clemmensen, Mikkel S Petersen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 27, 2025
[Correction: Chronic thromboembolic pulmonary hypertension]
John-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Plos One
|
May 23, 2012
Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure
Liv I Bjoner Sikkeland, Christen P Dahl, Thor Ueland, et al.
Clinical Transplantation
|
May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial
Kaspar Broch, Einar Gude, Kristjan Karason, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 27, 2025
Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosis
Margrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 22, 2024
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
Entela Bollano, Arne K Andreassen, Hans Eiskjaer, et al.
ESC Heart Failure
|
June 27, 2025
Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF guidelines
Kristian Berge, Henrik Schirmer, Tarjei Øvrebotten, et al.
Page
of 39
Search research articles
Search
Showing results (251-260 of 382) with videos related to
Sort By:
Page
of 39
Clinical Transplantation
|
November 22, 2024
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
Ingelin Grov, Anne Relbo Authen, Satish Arora, et al.
Clinical Transplantation
|
June 23, 2017
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
Anne Relbo Authen, Ingelin Grov, Kristjan Karason, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 27, 2025
Chronic thromboembolic pulmonary hypertension
John-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Human Immunology
|
October 22, 2023
Kinetics of Torque Teno virus in heart transplant patients
Randi Berg, Tor S Clemmensen, Mikkel S Petersen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 27, 2025
[Correction: Chronic thromboembolic pulmonary hypertension]
John-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Plos One
|
May 23, 2012
Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure
Liv I Bjoner Sikkeland, Christen P Dahl, Thor Ueland, et al.
Clinical Transplantation
|
May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial
Kaspar Broch, Einar Gude, Kristjan Karason, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 27, 2025
Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosis
Margrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 22, 2024
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
Entela Bollano, Arne K Andreassen, Hans Eiskjaer, et al.
ESC Heart Failure
|
June 27, 2025
Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF guidelines
Kristian Berge, Henrik Schirmer, Tarjei Øvrebotten, et al.
Page
of 39